Valor2022202320242025Total de pasivos3.51 M7.09 M6.52 M7.33 MCapital total8.51 M477.51 K3.63 M2.38 MTotal de pasivos y patrimonio neto12.02 M7.57 M10.16 M9.7 MDeuda total————Deuda neta————
MAIA Biotechnology Inc
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.